Virtanen KA - Search Results

1

Cold-stimulated brown adipose tissue activation is related to changes in serum metabolites relevant to NAD⁺ metabolism in humans.

U-Din M, de Mello VD, Tuomainen M, Raiko J, Niemi T, Fromme T, Klåvus A, Gautier N, Haimilahti K, Lehtonen M, Kristiansen K, Newman JW, Pietiläinen KH, Pihlajamäki J, Amri EZ, Klingenspor M, Nuutila P, Pirinen E, Hanhineva K, Virtanen KA. U-Din M, et al. Among authors: virtanen ka. Cell Rep. 2023 Sep 26;42(9):113131. doi: 10.1016/j.celrep.2023.113131. Epub 2023 Sep 13. Cell Rep. 2023. PMID: 37708023 Free article.

2

2-[(18)F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats.

Virtanen KA, Haaparanta M, Grönroos T, Bergman J, Solin O, Rouru J, Nuutila P, Huupponen R. Virtanen KA, et al. Diabetes Obes Metab. 2002 Jan;4(1):60-8. doi: 10.1046/j.1463-1326.2002.00185.x. Diabetes Obes Metab. 2002. PMID: 11874444

3

Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans.

Virtanen KA, Lönnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Rönnemaa T, Huupponen R, Nuutila P. Virtanen KA, et al. J Clin Endocrinol Metab. 2002 Aug;87(8):3902-10. doi: 10.1210/jcem.87.8.8761. J Clin Endocrinol Metab. 2002. PMID: 12161530 Clinical Trial.

4

Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET.

Asola MR, Virtanen KA, Peltoniemi P, Någren K, Yu M, Mattila K, Jyrkkiö S, Metsärinne K, Nuutila P, Knuuti J. Asola MR, et al. Among authors: virtanen ka. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1485-91. doi: 10.1007/s00259-002-0921-3. Epub 2002 Aug 30. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397468 Clinical Trial.

5

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.

Hällsten K, Virtanen KA, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, Rönnemaa T, Viikari J, Knuuti J, Nuutila P. Hällsten K, et al. Among authors: virtanen ka. Diabetes. 2002 Dec;51(12):3479-85. doi: 10.2337/diabetes.51.12.3479. Diabetes. 2002. PMID: 12453903 Clinical Trial.

6

Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

Virtanen KA, Hällsten K, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, Lönnroth P, Nuutila P. Virtanen KA, et al. Diabetes. 2003 Feb;52(2):283-90. doi: 10.2337/diabetes.52.2.283. Diabetes. 2003. PMID: 12540598 Clinical Trial.

7

Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.

Hällsten K, Virtanen KA, Lönnqvist F, Janatuinen T, Turiceanu M, Rönnemaa T, Viikari J, Lehtimäki T, Knuuti J, Nuutila P. Hällsten K, et al. Among authors: virtanen ka. Diabet Med. 2004 Dec;21(12):1280-7. doi: 10.1111/j.1464-5491.2004.01332.x. Diabet Med. 2004. PMID: 15569129 Clinical Trial.

8

The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.

Vänttinen M, Nuutila P, Pihlajamäki J, Hällsten K, Virtanen KA, Lautamäki R, Peltoniemi P, Kemppainen J, Takala T, Viljanen AP, Knuuti J, Laakso M. Vänttinen M, et al. Among authors: virtanen ka. J Clin Endocrinol Metab. 2005 Jul;90(7):4249-54. doi: 10.1210/jc.2005-0101. Epub 2005 Apr 26. J Clin Endocrinol Metab. 2005. PMID: 15855261

9

Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.

Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Lönnroth P, Knuuti J, Ferrannini E, Nuutila P. Virtanen KA, et al. Diabetes. 2005 Sep;54(9):2720-6. doi: 10.2337/diabetes.54.9.2720. Diabetes. 2005. PMID: 16123362

10

Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.

Viljanen AP, Virtanen KA, Järvisalo MJ, Hällsten K, Parkkola R, Rönnemaa T, Lönnqvist F, Iozzo P, Ferrannini E, Nuutila P. Viljanen AP, et al. Among authors: virtanen ka. J Clin Endocrinol Metab. 2005 Dec;90(12):6523-8. doi: 10.1210/jc.2005-1073. Epub 2005 Sep 27. J Clin Endocrinol Metab. 2005. PMID: 16189256 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page